Literature DB >> 25815673

Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.

Ramesh C Mishra1, Heike Wulff, Michael A Hill, Andrew P Braun.   

Abstract

Endothelial KCa2.3 and KCa3.1 channels contribute to the regulation of myogenic tone in resistance arteries by Ca(2+)-mobilizing vasodilatory hormones. To define further the functional role of these channels in distinct vascular beds, we have examined the vasodilatory actions of the KCa channel activator SKA-31 in myogenically active rat cremaster and middle cerebral arteries. Vessels pressurized to 70 mm Hg constricted by 80-100 μm (ie, 25%-45% of maximal diameter). SKA-31 (10 μM) inhibited myogenic tone by 80% in cremaster and ∼65% in middle cerebral arteries, with IC50 values of ∼2 μM in both vessels. These vasodilatory effects were largely prevented by the KCa2.3 blocker UCL1684 and the KCa3.1 blocker TRAM-34 and abolished by endothelial denudation. Preincubation with N(G) nitro L-arginine methyl ester (L-NAME, 0.1 mM) did not affect the inhibitory response to SKA-31, but attenuated the ACh-evoked dilation by ∼45%. Penitrem-A, a blocker of BK(Ca) channels, did not alter SKA-31 evoked vasodilation but did reduce the inhibition of myogenic tone by ACh, the BKCa channel activator NS1619, and sodium nitroprusside. Collectively, these data demonstrate that SKA-31 produces robust inhibition of myogenic tone in resistance arteries isolated from distinct vascular beds in an endothelium-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815673      PMCID: PMC4500737          DOI: 10.1097/FJC.0000000000000252

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  48 in total

1.  Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation.

Authors:  Jian-zhong Sheng; Srikanth Ella; Michael J Davis; Michael A Hill; Andrew P Braun
Journal:  FASEB J       Date:  2008-12-12       Impact factor: 5.191

Review 2.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

Review 3.  Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Authors:  Ivica Grgic; Brajesh P Kaistha; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

Review 4.  BK channel modulators: a comprehensive overview.

Authors:  Antonio Nardi; Søren-Peter Olesen
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.

Authors:  Ananthakrishnan Sankaranarayanan; Girija Raman; Christoph Busch; Tim Schultz; Pavel I Zimin; Joachim Hoyer; Ralf Köhler; Heike Wulff
Journal:  Mol Pharmacol       Date:  2008-10-27       Impact factor: 4.436

6.  Endothelium-independent constriction of isolated, pressurized arterioles by Nomega-nitro-L-arginine methyl ester (L-NAME).

Authors:  T V Murphy; N Kotecha; M A Hill
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 7.  The endothelium-derived hyperpolarizing factor: insights from genetic animal models.

Authors:  R Köhler; J Hoyer
Journal:  Kidney Int       Date:  2007-04-25       Impact factor: 10.612

8.  Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension.

Authors:  Sebastian Brähler; Anuradha Kaistha; Volker J Schmidt; Stephanie E Wölfle; Christoph Busch; Brajesh P Kaistha; Michael Kacik; Anna-Lena Hasenau; Ivica Grgic; Han Si; Chris T Bond; John P Adelman; Heike Wulff; Cor de Wit; Joachim Hoyer; Ralf Köhler
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

9.  Endothelium-dependent vasodilation in myogenically active mouse skeletal muscle arterioles: role of EDH and K(+) channels.

Authors:  Simon J Potocnik; Iain McSherry; Hong Ding; Timothy V Murphy; Neela Kotecha; Kim A Dora; Kathryn H Yuill; Chris R Triggle; Michael A Hill
Journal:  Microcirculation       Date:  2009-05-07       Impact factor: 2.628

Review 10.  Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.

Authors:  Heike Wulff; Aaron Kolski-Andreaco; Ananthakrishnan Sankaranarayanan; Jean-Marc Sabatier; Vikram Shakkottai
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more
  10 in total

1.  The augmentation of BK channel activity by nitric oxide signaling in rat cerebral arteries involves co-localized regulatory elements.

Authors:  Barry D Kyle; Ramesh C Mishra; Andrew P Braun
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-03       Impact factor: 6.200

2.  SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging.

Authors:  Cini Mathew John; Rayan Khaddaj Mallat; Ramesh C Mishra; Grace George; Vikrant Singh; Jeannine D Turnbull; Channakeshava S Umeshappa; Dylan J Kendrick; Taeyeob Kim; Fazlin M Fauzi; Frank Visser; Paul W M Fedak; Heike Wulff; Andrew P Braun
Journal:  Pharmacol Res       Date:  2019-11-07       Impact factor: 7.658

3.  Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats.

Authors:  Kathleen M Lukaszewicz; Matthew J Durand; Jessica R C Priestley; James R Schmidt; L Adrienne Allen; Aron M Geurts; Julian H Lombard
Journal:  J Vis Exp       Date:  2017-12-05       Impact factor: 1.355

4.  Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating KCa3.1 channel via ERK1/2 pathway.

Authors:  Li-Ping Wang; Su-Jing Fan; Shu-Min Li; Xiao-Jun Wang; Jun-Ling Gao; Xiu-Hong Yang
Journal:  Pflugers Arch       Date:  2016-09-03       Impact factor: 3.657

5.  A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig model.

Authors:  Ramesh C Mishra; Jamie R Mitchell; Carol Gibbons-Kroeker; Heike Wulff; Israel Belenkie; John V Tyberg; Andrew P Braun
Journal:  Vascul Pharmacol       Date:  2015-08-01       Impact factor: 5.773

6.  Development of Alzheimer's Disease Progressively Alters Sex-Dependent KCa and Sex-Independent KIR Channel Function in Cerebrovascular Endothelium.

Authors:  Md A Hakim; Erik J Behringer
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca2+ mobilization.

Authors:  Ramesh C Mishra; Barry D Kyle; Dylan J Kendrick; Daniyil Svystonyuk; Teresa M Kieser; Paul W M Fedak; Heike Wulff; Andrew P Braun
Journal:  Metabolism       Date:  2020-10-08       Impact factor: 8.694

Review 8.  Pharmacologic targeting of endothelial Ca2+-activated K+ channels: A strategy to improve cardiovascular function.

Authors:  Cini Mathew John; Rayan Khaddaj Mallat; Grace George; Taeyeob Kim; Ramesh C Mishra; Andrew P Braun
Journal:  Channels (Austin)       Date:  2018-01-01       Impact factor: 2.581

9.  Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries.

Authors:  Dylan J Kendrick; Ramesh C Mishra; Cini Mathew John; Hai-Lei Zhu; Andrew P Braun
Journal:  Front Physiol       Date:  2022-01-24       Impact factor: 4.566

10.  Alpha1 -adrenergic stimulation selectively enhances endothelium-mediated vasodilation in rat cremaster arteries.

Authors:  Ramesh C Mishra; Mohammad M Rahman; Michael J Davis; Heike Wulff; Michael A Hill; Andrew P Braun
Journal:  Physiol Rep       Date:  2018-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.